Orofacial dystonia related to Sjogren's syndrome

Clinical Rheumatology

Volumn 26, Issue 10, 2007, Pages 1779-1781

  Papageorgiou, Sokratis G ^a   Kontaxis, Theodoros ^a   Bonakis, Anastasios ^a   Kalfakis, Nikolaos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Dystonia; Orofacial dystonia; Sjogren's syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; CLONAZEPAM; DOPAMINE; ETIRACETAM; METHYLPREDNISOLONE; PREDNISONE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; RHEUMATOID FACTOR; CORTICOSTEROID; DRUG DERIVATIVE; PIRACETAM;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CELIAC DISEASE; CONTRACTURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DYSKINESIA; DYSPHONIA; DYSTONIA; FATIGUE; FEMALE; GLUTEN FREE DIET; HEADACHE; HUMAN; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; INTESTINE BIOPSY; ORAFACIAL DYSTONIA; OROFACIAL DYSTONIA; PRIORITY JOURNAL; SALIVARY GLAND BIOPSY; SENSORY DYSFUNCTION; SJOEGREN SYNDROME; TONGUE DISEASE; WEIGHT REDUCTION; XEROSTOMIA; BRAIN; FACE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REMISSION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; BRAIN; CLONAZEPAM; DYSTONIA; DYSTONIC DISORDERS; FACE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PIRACETAM; REMISSION INDUCTION; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 38349017326     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0519-4     Document Type: Article

References (10)

1. P Venegas Fanchke M Sinning M Miranda 2005 Primary Sjogren's syndrome presenting as a generalized chorea Parkinsonism Relat Disord 11 193 194 15823485 10.1016/j.parkreldis.2004.10.006 1:STN:280:DC%2BD2M7ptFClsA%3D%3D
2. S Delalande J de Seze AL Fauchais, et al. 2004 Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients Medicine (Baltimore) 83 280 291 10.1097/01.md.0000141099.53742.16 (Pubitemid 39258414)
3. JS van den Berg MW Horstink FH van den Hoogen, et al. 1999 Dystonia; a central nervous system presentation of Sjogren's syndrome Mov Disord 14 374 375 10091641 10.1002/1531-8257(199903)14:2<374::AID-MDS1032>3.0.CO;2-W (Pubitemid 30011865)
4. EL Alexander 1993 Neurologic disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis Rheum Dis Clin North Am 19 869 908 8265827 1:STN:280:ByuD1cbpslA%3D
5. S Bakchine C Duyckaerts L Hassine, et al. 1991 Central and peripheral neurologic lesions in primary Gougerot-Sjogren syndrome. Clinicopathological study of a case Rev Neurol (Paris) 147 368 375 1:STN:280:By6A3crnsVI%3D
6. M Govoni M Padovan N Rizzo, et al. 2001 CNS involvement in primary Sjogren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach CNS Drugs 15 597 607 11524032 10.2165/00023210-200115080- 00003 1:STN:280:DC%2BD3MvotV2htg%3D%3D
7. C Lafitte Z Amoura P Cacoub, et al. 2001 Neurological complications of primary Sjogren's syndrome J Neurol 248 577 584 11517999 10.1007/s004150170135 1:STN:280:DC%2BD3MvnsVGhsA%3D%3D (Pubitemid 32695799)
8. A Creange F Sedel P Brugieres, et al. 1997 Primary Sjogren's syndrome presenting as progressive parkinsonian syndrome Mov Disord 12 121 123 8990068 10.1002/mds.870120124 1:STN:280:ByiC2cvisVY%3D (Pubitemid 27032894)
9. AC Pereira MJ Edwards PC Buttery, et al. 2004 Choreic syndrome and coeliac disease: a hitherto unrecognised association Mov Disord 19 478 482 15077250 10.1002/mds.10691 (Pubitemid 38559655)
10. VS Fung A Duggins JG Morris, et al. 2000 Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia Mov Disord 15 732 734 10928587 10.1002/1531-8257(200007)15:4<732:: AID-MDS1021>3.0.CO;2-J 1:STN:280:DC%2BD3M%2FotlWqtQ%3D%3D (Pubitemid 30479629)